Timothy Walbert was appointed chair of the board of directors of Latigo Biotherapeutics, a clinical-stage biotechnology company developing best-in-class non-opioid pain medicines.
Fitzpatrick Lentz & Bubba employs Mules from the classes of 1978, 1994, 2005, 2008, 2021, and 2022 […]
In 2025, Ali Calamoneri ’18 and Noah Fulcomer ’19 spent five months hiking the Pacific Crest […]
Timothy Walbert was appointed chair of the board of directors of Latigo Biotherapeutics, a clinical-stage biotechnology company developing best-in-class non-opioid pain medicines.
